$SBFM News
Last published 2w ago
- 2w agoSBFMSunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ ListingACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 22, 2026 / Sunshine Biopharma Inc. , a pharmaceutical company specializing in generic and specialty prescription medications,
- 1mo agoSBFMSunshine Biopharma Announces Closing of up to $20.4 Million Public OfferingACCESS Newswire$6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrants FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2026 / Sunshine Biopharma Inc.
- 1mo agoSBFMSunshine Biopharma Inc. Announces Pricing of $6.0 Million Public OfferingACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 8, 2026 / Sunshine Biopharma Inc. , a pharmaceutical company specializing in generic and specialty prescription medications, including
- 1mo agoSBFMSunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care PortfolioACCESS NewswireLaunch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgeryGlobal ondansetron market projected to reach $2.98 billion by 2034, up from $1.82
- 1mo agoSBFMSunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling StudiesACCESS NewswireNanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activitySignificant dose-dependent suppression of pulmonary viral replication in vivoStrong oral bioavailability and preferential lung enrichment
- 2mo agoSBFMHealth Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular ConditionsACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / August 31, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications,
- 2mo agoSBFMBNTXAZNMRNA+1A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest OpportunityGlobeNewswireNEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is
- 2mo agoSBFMSunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung CancerACCESS NewswireK1.1 mRNA demonstrated tumor-suppressing activity as a single agent in multiple in vivo hepatocellular carcinoma modelsProgram targets a tumor suppressor frequently mutated in difficult-to-treat lung, pancreatic and
- 2mo agoSBFMSunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug MarketACCESS NewswireGlobal anti-hypertensive drug market projected to reach $37.24 billion by 2034Enalapril is a widely prescribed ACE inhibitor used to treat hypertension, heart failure and left ventricular dysfunctionSunshine Biopharma
- 3mo agoSBFMSunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global MarketACCESS NewswireSunshine Biopharma's Amoxicillin now shipping to Canadian pharmacies in multiple dosages and strengthsLaunch expands Sunshine Biopharma's growing portfolio of essential prescription medicationsGlobal Amoxicillin
- 3mo agoSBFMSunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory ApprovalACCESS NewswireDienogest is first-line therapy for pelvic pain associate with endometriosisThe endometriosis treatment market is projected to reach $5.2 billion by 2034 FORT LAUDERDALE, FL / ACCESS Newswire / August 4, 2026 / Sunshine
- 3mo agoSBFMHealth Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and VomitingACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / July 28, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications, is
- 3mo agoSBFMSunshine Biopharma and University of Arizona Publish Significant New Research FindingsACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / July 20, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications
- 4mo agoSBFMSunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)ACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / June 25, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications, is
- 5mo agoSBFMSunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)ACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to
- 5mo agoSBFMSunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment TechnologyACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications, today
- 5mo agoSBFMSunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ ListingACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / May 28, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications, today
- 5mo agoSBFMSunshine Biopharma Receives Canadian Regulatory Approval for Generic AmoxicillinACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / May 21, 2026 / Sunshine Biopharma Inc. , a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to
- 5mo agoSBFMSunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public OfferingACCESS Newswire$6.0 million upfront with up to an additional approximately $12.0 million of potential aggregate gross proceeds upon the exercise in full of warrants. FORT LAUDERDALE, FL / ACCESS Newswire / May 19, 2026 / Sunshine
- 5mo agoSBFMSunshine Biopharma Inc. Announces Pricing of $6.0 Million Public OfferingACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / May 18, 2026 / Sunshine Biopharma Inc. , a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other
- 7mo agoSBFMSunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior YearACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / April 6, 2026 / Sunshine Biopharma Inc. , a pharmaceutical company offering and developing life‑saving medicines across
- 1y agoSBFMSunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)ACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma is quickly establishing which side of that line it's on. After
- 1y agoSBFMSunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related NauseaACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. , a leading pharmaceutical company focused on innovative and affordable healthcare solutions,
- 1y agoSBFMSunshine Biopharma Launches STD, Acne and Lyme Disease Therapy DoxycyclineACCESS NewswireFORT LAUDERDALE, FL, QC / ACCESS Newswire / October 20, 2025 / Sunshine Biopharma Inc. , a leading pharmaceutical company focused on innovative and affordable healthcare solutions,
- 1y agoSBFMSunshine Biopharma Launches Cholesterol Fighting Medicine PravastatinACCESS NewswireFORT LAUDERDALE, FL, QC / ACCESS Newswire / October 16, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of
- 1y agoSBFMSunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)ACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 14, 2025 / Sunshine Biopharma is quietly engineering a flywheel model for biotech. Not a flashy one that spins fast and burns energy and cash quickly. A lean
- 1y agoSBFMSunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)ACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 14, 2025 / Sunshine Biopharma is the kind of company that keeps the market honest. On paper, it's small, barely a rounding error next to the giants of
- 1y agoSBFMSunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury ResilienceACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 14, 2025 / Sunshine Biopharma Inc. , a leading pharmaceutical company offering and researching life-saving medicines in a variety of
- 1y agoSBFMSunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus InfectionsACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of
- 1y agoSBFMSunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics MarketACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / July 2, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion MarketACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / June 11, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last YearACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion MarketACCESS NewswireFORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 BillionACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology
- 1y agoSBFMSunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct OfferingACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq RulesACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Announces Positive Results of mRNA Therapy for CancerACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving
- 1y agoSBFMSunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last YearACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in CanadaACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / March 24, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology
- 1y agoSBFMSunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million MarketACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / March 10, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology
- 1y agoSBFMSunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODTACCESS NewswireFORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of
- 1y agoSBFMSunshine Biopharma Announces the Appointment of New Chief Commercial OfficerACCESS NewswireFORT LAUDERDALE, FL / ACCESSWIRE / January 15, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Announces Novel Inhibitor for Sars CoronavirusACCESS NewswireFORT LAUDERDALE, FL / ACCESSWIRE / December 9, 2024 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 1y agoSBFMSunshine Biopharma Launches a New Generic Prescription DrugACCESS NewswireFORT LAUDERDALE, FL / ACCESSWIRE / December 4, 2024 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of
- 1y agoSBFMSunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular CarcinomaACCESS NewswireFORT LAUDERDALE, FL / ACCESSWIRE / December 2, 2024 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of
- 1y agoSBFMSunshine Biopharma Launches a New Generic Prescription DrugACCESS NewswireFORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 2y agoSBFMSunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%ACCESS NewswireFORT LAUDERDALE, FL / ACCESSWIRE / November 6, 2024 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic
- 2y agoSBFMSunshine Biopharma Launches Two New Generic Prescription DrugsACCESS NewswireFORT LAUDERDALE, FL / ACCESSWIRE / September 26, 2024 / Sunshine Biopharma, Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of
- 2y agoABBVBNTXNVAXRGNX+1New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market GrowthGlobeNewswirePALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for therapies and
- 2y agoINOMRNAPFESBFM+1Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031GlobeNewswirePALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The emergence of SARS-CoV-2, which triggered the COVID-19 pandemic with overall is widely regarded as the greatest medical emergency